NANOG and hepatocellular carcinoma: Notably, although a high level of Nanog expression correlates with a poor prognosis and sorafenib resistance in HCC, how Nanog is induced through these regulatory mechanisms is unknown (Jeter et al., 2015; Shan et al., 2012).